2028 年栓塞剂市场报告(按细分市场、地域、动态、最新发展和战略见解)

  • Report Code : TIPRE00025058
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 219
Buy Now

栓塞剂市场规模预计将从 2021 年的 27.1482 亿美元增至 2028 年的 45.2575 亿美元;预计 2021 年至 2028 年的复合年增长率为 7.6%。

市场的增长归因于肿瘤和动脉瘤发病率的上升以及高血压、肥胖、吸烟和酗酒的患病率的上升。然而,栓塞剂的高成本限制了栓塞剂市场的增长。栓塞剂用于应用机械闭塞以阻止血管或血管区域的血液流动。在介入放射学中,栓塞是一种常见的手术。栓塞手术主要用于治疗创伤。栓塞剂有多种形式,每种都有自己的一套特性和应用。根据动脉闭塞所需的时间,栓塞剂分为暂时性栓塞剂和永久性栓塞剂。

在美国,由于重点转向 COVID-19 治疗,对疣治疗程序的需求有所减少。COVID-19 大流行给全球供应链、消费市场和经济造成了严重破坏。这种情况导致亚太地区各国进行的心脏手术数量下降。世界各国政府实施的措施对栓塞剂市场增长产生了负面影响。

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

栓塞剂市场:

Embolization Agents Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

 

市场洞察
肿瘤和动脉瘤发病率上升推动栓塞剂市场增长


根据美国国家癌症研究所的数据,2020 年,美国新增癌症病例 1,806,590 例,癌症死亡人数 606,520 人。2020 年,前列腺癌、肺癌和结直肠癌占男性确诊癌症总数的 43%。乳腺癌、肺癌和结直肠癌是女性最常见的三种癌症。根据脑动脉瘤基金会的统计和事实报告,在美国,约有 650 万人,即每 50 人中就有 1 人患有未破裂的脑动脉瘤。报告还提到,在所有被诊断患有脑动脉瘤的人中,有 20% 的人患有多个动脉瘤。报告进一步指出,每年美国约有 3 万人患有脑动脉瘤破裂,每 18 分钟就会发生一次脑动脉瘤破裂。此外,根据 NHS 的数据,英国每年每 12,500 人中就有 1 人患有脑动脉瘤破裂。此外,根据 2020 年在《德国国际新闻报》上发表的《未破裂颅内动脉瘤发病机制和个体化治疗》报告,德国约有 200 万人(成年人)患有未破裂颅内动脉瘤 (IA)。栓塞剂用于通过机械闭塞的方式急性阻止血管或血管区域中的血流。栓塞剂(例如栓塞微球(珠))用于限制对肿瘤的血管供应,并可装载化疗药物,这些药物会洗脱并扩散到组织中。液体栓塞剂用于阻止对动脉瘤或肿瘤的血液供应。因此,动脉瘤和癌症的发病率不断上升,对栓塞剂的需求也很高。

 

基于产品的洞察

根据产品,栓塞剂市场细分为线圈、珠子/颗粒、栓塞、可拆卸球囊、胶水、海绵、液体栓塞剂、硬化剂、沉淀剂等。珠子/颗粒部分占据最大的市场份额。然而,线圈部分预计在 2021-2028 年期间的复合年增长率最高。线圈栓塞是一种基于导管的手术,可以精确阻塞血管中的异常血流。心脏手术数量的增加推动了这一细分市场的市场增长。

基于应用程序的见解

根据应用,栓塞剂市场分为神经病学、肿瘤学、心脏病学、外周血管疾病等。肿瘤学领域占据最大的市场份额,预计在预测期内将实现最高的复合年增长率。

基于最终用户的洞察

根据最终用户,栓塞剂市场分为医院、门诊手术中心、心脏中心和其他。医院部分占有最大的市场份额,预计在预测期内将实现最高的复合年增长率。该部分的市场增长归因于全球医院数量的增加和外科手术数量的快速增长。

栓塞剂市场中的公司正在采用产品创新战略来满足全球不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌名称。

 

栓塞剂市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响栓塞剂市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的栓塞剂市场细分和地理位置。

Embolization Agents Market
  • 获取栓塞剂市场的区域特定数据

栓塞剂市场报告范围

报告属性细节
2021 年市场规模27.1亿美元
2028 年市场规模45.3亿美元
全球复合年增长率(2021 - 2028)7.6%
史料2019-2020
预测期2022-2028
涵盖的领域按产品
  • 线圈
  • 插头
  • 珠子/颗粒
  • 可拆卸气球
  • 胶水
  • 海绵
  • 液体栓塞剂
  • 硬化剂
  • 沉淀剂
按应用
  • 肿瘤学
  • 神经病学
  • 泌尿科
  • 心脏病学
  • 周围血管疾病
按最终用户
  • 医院
  • 心脏中心
  • 门诊手术中心
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 美敦力
  • 泰尔茂株式会社
  • 库克医疗有限责任公司
  • 波士顿科学公司
  • 雅培
  • 史赛克公司
  • 半影股份有限公司
  • Merit Medical Systems Inc.
  • 德普合成公司

市场参与者密度:了解其对商业动态的影响

栓塞剂市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在栓塞剂市场运营的主要公司有:

  1. 美敦力
  2. 泰尔茂株式会社
  3. 库克医疗有限责任公司
  4. 波士顿科学公司
  5. 雅培

免责声明上面列出的公司没有按照任何特定顺序排列。


Embolization Agents Market

 

  • 获取栓塞剂市场顶级关键参与者概述

栓塞剂市场 – 按产品分类

  • 线圈
    • 可拆卸线圈
    • 可推式线圈
  • 珠子/颗粒
    • 球形
    • 非球面
  • 插头
  • 可拆卸气球
  • 胶水
  • 海绵
  • 液体栓塞剂
  • 硬化剂
  • 沉淀剂
  • 其他的

栓塞剂市场——按应用分类

  • 肿瘤学
  • 神经病学
  • 泌尿科
  • 心脏病学
  • 周围血管疾病
  • 其他的

栓塞剂市场 – 按最终用户划分

  • 医院
  • 心脏中心
  • 门诊手术中心
  • 其他的

栓塞剂市场——按地区划分

  • 北美

    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲

    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区 (APAC)

    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲 (MEA)

    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • MEA 其他地区
  • 南美洲和中美洲(SCAM)

    • 巴西
    • 阿根廷
    • 其余的骗局

公司简介

  • 美敦力
  • 泰尔茂株式会社
  • 库克医疗有限责任公司
  • 波士顿科学公司
  • 雅培
  • 史赛克公司
  • 半影股份有限公司
  • Merit Medical Systems Inc.
  • 德普合成公司
  • 钟化株式会社
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the embolization agents market across the globe?

The factors that are driving growth of the market are rising incidence of tumors and aneurysms, and growing incidence of hypertension, obesity, smoking, and alcoholism.

What are embolization agents?

Embolization agents are used to apply mechanical occlusion to stop the flow of blood in a blood vessel or vascular area. In interventional radiology, embolization is a common procedure. Embolization procedures are most used to treat traumatic injuries. Embolic agents come in a variety of forms, each with its own set of properties and applications. Depending on the duration of time that arterial occlusion is required, embolization agents are classified as temporary or permanent.

Who are the developments carrying out by major players in the embolization agents market?

Various companies have made organic growth strategies in the embolization agents market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Medtronic, Cook Medical LLC amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

Which region is the fastest growing in the embolization agents market?

Asia Pacific is expected to be the fastest growing region in the embolization agents market. The growth of the market in this region is primarily due to factors such as rising prevalence of the brain stroke, coronary artery diseases, heart diseases, increasing surgical procedures, growing number of hospitals and ambulatory surgeries centers, focus by industry players in Japan and developing healthcare infrastructure in India are likely to boost the market growth in forecast period.

Which segment is growing at the highest CAGR in the embolization agents market?

The coil segment is growing at the highest CAGR owing to increasing number of cardiac surgeries.

Which region is dominated the embolization agents market?

North America dominates the global embolization agents market due to factors such as increasing incidences of the neurological disorders such as stroke, brain aneurysms and others across the country, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Embolization Agents Market

  1. Medtronic
  2. Terumo Corporation
  3. Cook Medical LLC
  4. Boston Scientific Corporation
  5. Abbott
  6. Stryker Corporation
  7. Penumbra, Inc.
  8. Merit Medical Systems Inc.
  9. DePuy Synthes
  10. KANEKA CORPORATION            

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.